Skip to main content

Spina Bifida

1
Pipeline Programs
4
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Farco-Pharma
Farco-PharmaGermany - Cologne
1 program
1
Oxybutynin HydrochloridePhase 31 trial
Active Trials
NCT07027020Recruiting60Est. Jun 2028
Augustine Therapeutics
Augustine TherapeuticsBelgium - Leuven
1 program
Altimate Medical EasyStand BantamN/A2 trials
Active Trials
NCT06419049Recruiting12Est. Aug 2025
NCT05251740Completed1Est. Jul 2021
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
PedMMSWC Wheelchair User TestingN/A1 trial
Active Trials
NCT07290556Not Yet Recruiting30Est. Aug 2027
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Use of the foley catheter assistive deviceN/A1 trial
Active Trials
NCT05253196Not Yet Recruiting20Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Farco-PharmaOxybutynin Hydrochloride
Human BioSciencesPedMMSWC Wheelchair User Testing
Colorado TherapeuticsUse of the foley catheter assistive device
Augustine TherapeuticsAltimate Medical EasyStand Bantam
Augustine TherapeuticsAltimate Medical EasyStand Bantam

Clinical Trials (5)

Total enrollment: 123 patients across 5 trials

NCT07027020Farco-PharmaOxybutynin Hydrochloride

Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction

Start: Jan 2026Est. completion: Jun 202860 patients
Phase 3Recruiting
NCT07290556Human BioSciencesPedMMSWC Wheelchair User Testing

Establishing the Preliminary Utility of a Novel Pediatric Manual Mobile Standing Wheelchair

Start: May 2026Est. completion: Aug 202730 patients
N/ANot Yet Recruiting
NCT05253196Colorado TherapeuticsUse of the foley catheter assistive device

Enema Device for Children With Spina Bifida

Start: Jun 2025Est. completion: Jun 202720 patients
N/ANot Yet Recruiting
NCT06419049Augustine TherapeuticsAltimate Medical EasyStand Bantam

Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design

Start: Feb 2023Est. completion: Aug 202512 patients
N/ARecruiting
NCT05251740Augustine TherapeuticsAltimate Medical EasyStand Bantam

Impact of a Standing Program in a Child With Spina Bifida: A Case Report

Start: May 2021Est. completion: Jul 20211 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 actively recruiting trials targeting 123 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.